Quantcast

Germany's Merck sells generic drug business to Mylan for $6.6 billion

German drug maker Merck KGaA announced Sunday that it is selling its generic drug business to Mylan Laboratories Inc. of the U.S. for $6.6 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *

*